baber/WOPTO huggingface dataset:
Patent AU-544392-B2 (AU)
Title: Cleaning machine
Inventor: MOSELL C G C
IPC: B08B3/02
Filed: 1980-04-01
Granted: 1985-05-23
Abstract: Cleaning machine with means for blasting the goods to be cleaned.  f side a liquid container (23) there is provided a liquid-permeable compartment or cassette providing a magazine for the granules and connected to a bottom outlet (36, 36 min ) in a treatment chamber (12) wherein the blasting shall take place. The compartment or cassette is connected by a valve-controlled opening (45, 45 min ) to the suction side of pump means (25) for sucking-in liquid from the liquid container via the cassette while carrying granules therefrom, and for supplying the liquid containing granules to the treatment chamber from which the granules are again supplied to the cassette through the bottom outlet.
Patent AU-769270-B2 (AU)
Title: Stoma opening forming apparatus
Inventor: FORSELL PETER
IPC: A61B19/00
Filed: 2000-08-01
Granted: 2004-01-22
Abstract: In the treatment of morbid obesity or heartburn and reflux disease an elongated restriction member (12) is formed in a substantially closed loop around a human's stomach or esophagus to form a stoma opening in the stomach or esophagus. The size of the stoma opening is adjustable by an implanted adjustment device. A control device (22) is utilized to control the adjustment device, in order to either reduce or enlarge the size of the stoma opening, for example in response to the time of the day. Nausea in a treated obese human can be minimized or substantially eliminated as a result of the control device controlling the adjustment device to keep the stoma opening substantially fully open between meals (such as at night when the human is sleeping). A sensor (23), such as a pressure or position sensor, is surgically implanted in the human's body so that the sensor may either directly or indirectly sense a physical parameter of the human, such as the pressure in the stomach or the human's orientation with respect to the horizontal. If in response to sensing by the sensor it is determined by the control device that a significant change in the physical parameter has occurred, then the control device controls the adjustment device to either reduce or enlarge the size of the stoma opening.
Patent AU-648278-B2 (AU)
Title: Sustained release compositions for treating periodontal disease
Inventor: DAMANI NALINKANT CHUNILAL
IPC: A61K31/65
Filed: 1990-11-16
Granted: 1994-04-21
Abstract: This invention relates to compositions/devices and methods for treating diseases of the oral cavity in humans and lower animals using polylactide/glycolide compositions/devices for releasing drugs in the oral cavity.
Patent AU-713809-B2 (AU)
Title: Pharmaceutical composition containing inhibitors of interferon- gamma
Inventor: FERGUSON MARK WILLIAM JAMES
IPC: A61K38/21
Filed: 1996-08-09
Granted: 1999-12-09
Abstract: The present invention provides compositions for promoting the healing of chronic wounds comprising stimulators of IFN- gamma .
Patent AU-678248-B2 (AU)
Title: Liquid level sensing probe and control circuit
Inventor: RAMEY BLAINE EDWARD
IPC: G01F23/26
Filed: 1994-07-08
Granted: 1997-05-22
Abstract: A method and apparatus for a liquid level sensor control circuit of a bioassay apparatus for controlling a position of a sampling probe with respect to a surface of a liquid in a container. The apparatus includes a sampling probe, an oscillator circuit coupled to the sampling probe for producing a first output signal having a constant frequency, a comparator coupled to the oscillator circuit for comparing the amplitude of the first output signal to a first reference amplitude and for producing a change signal when the amplitude of the first output signal changes with respect to the reference amplitude, and a controller responsive to the change signal for controlling the position of the sampling probe with respect to the surface of the liquid. <IMAGE>
Patent AU-590378-B2 (AU)
Title: Anthraquinone drug composition and method
Inventor: BARENHOLZ YECHEZKEL
IPC: A61K31/70
Filed: 1987-01-14
Granted: 1989-11-02
Abstract: A drug/liposome composition comprises an aqueous suspension of liposomes and, entrapped in the lipid bilayer region of the liposomes, an anthraquinone drug containing quinone and hydroquinone functionalities on adjacent anthracene rings. An iron-specific trihydroxamic chelating agent contained in the bulk aqueous phase of the suspension and a lipophilic free-radical scavenger contained in the bilayer region of the liposome cooperate to reduce chemical modification of both drug and lipid components of the composition. The compositions can be used for administering doxorubicin intravenously to humans, with significantly reduced incidence of side effects, and for treating primary and secondary neoplasms of the liver.
Patent AU-739240-B2 (AU)
Title: Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
Inventor: SCHINAZI RAYMOND F
IPC: C07D421/04
Filed: 1998-03-19
Granted: 2001-10-04
Abstract: A method and composition for the treatment of HIV infection, HBV infection, or abnormal cellular proliferation in humans and other host animals is disclosed that includes the administration of an effective amount of a 1,3-oxaselenolane nucleoside or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
Patent AU-595867-B2 (AU)
Title: Tape loading apparatus
Inventor: SASAO TAKASHI
IPC: G11B15/665
Filed: 1987-03-18
Granted: 1990-04-12
Abstract: In a magnetic tape cassette recording and/or reproducing device (100) having a tape loading apparatus for withdrawing tape (17) from an operatively positioned cassette (14) and wrapping the withdrawn tape about a guide drum (11); supply and take-up reel motors (19,20) apply torques to resist unwinding of the tape (17) from supply and take-up reels (15,16) in the operatively positioned cassette, a servo-control (26) maintains the supply reel (16) in a stopped condition during a loading operation, the ratio of currents (IS, IT) supplied to the supply and take-up reel motors (19,20), respectively, for achieving the stopped condition of the supply reel (15) and for applying a constant torque to the take-up reel (16) is determined and the radius (RS, RT) of the tape (17) wound on one of the reels (15,16) is calculated from such ratio, whereupon, a value of the torque that has to be applied to that one reel is calculated in accordance with the calculated radius of the tape wound on that one reel.
Patent AU-633186-B2 (AU)
Title: Method and apparatus for optimum target call
IPC: B66B1/18
Filed: 1991-02-22
Granted: 1993-01-21
Abstract: In this method, destination calls (R(+)(-)) are immediately definitively allocated to the individual elevators (N) on the basis of higher- and lower-priority function requests to the call service and these allocations are immediately indicated at the input storeys (E1...E16). For this purpose, a weighted sum is formed from partial service costs (K1...Kn) which correspond to higher-priority function requests, this sum is modified by means of variable bonus/penalty factors (BF1...; MF1...) in the sense of lower-priority function requests with respect to service costs (KNR) and a destination call (R(+)(-)) is allocated to the elevator (N) with the lowest service costs (KNR). A destination call allocation algorithm (ZZA) according to steps 1 to 6 (SR1...SR6) with subordinate algorithms for the bonus/penalty tracking (NFA) and the cost calculation (KBA) is used for implementing this method. The tracking algorithm (NFA) is used for continuously correcting the bonus/penalty factors (BF1...; MF1...) group-by-group or elevator-by-elevator in accordance with the traffic load or cabin load. In the cost calculation algorithm (KBA), the operating costs (KNR) are calculated in accordance with a special cost formula, the corrected bonus/penalty factors (BF1...; MF1...) acting multiplicatively on a six-part partial cost sum. This allocation method improves, above all, the user-friendliness and the quantitative aspects of "waiting times" and "times to destination". It utilises capacity reserves during low traffic for additional function requests to the call service. 
<IMAGE>
Patent AU-685474-B2 (AU)
Title: A method of producing a coreless roll of fibre-based, web-like material
Inventor: ANDERSSON ANDERS
IPC: B65H19/22
Filed: 1994-07-05
Granted: 1998-01-22
Abstract: A method of producing a coreless roll from a web of fibre-based material, particularly soft crêpe paper or some other nonwoven material, for instance cleaning paper, kitchen paper or toilet paper. The web (2) is wound onto a non-expandable winding-on axle (3) having a diameter of between 35-100mm. In order to facilitate withdrawal of the axle from the roll after winding the web onto the roll, a friction-reducing agent (4) is applied to the axle or to the first turn or turns of the web. This agent may be water, to which a surfactant or some other lubricant is optionally added, or oil, triglyceride, silicone, Teflon<TM> or the like. The axle (2) may be heated, either electrically or with the aid of steam, in conjunction with applying the agent, therewith further reducing the friction between web and axle.
Patent AU-699805-B2 (AU)
Title: Compounds for the photodecontamination of pathogens in blood
Inventor: WOLLOWITZ SUSAN
IPC: A61K41/00
Filed: 1994-06-24
Granted: 1998-12-17
Abstract: Psoralen compounds are synthesized which have substitutions on the 4, 4', 5' and 8 positions of the psoralen, which permit enhanced binding to nucleic acid of pathogens.  Higher psoralen binding levels and lower mutagenicity are described, resulting in safer, more efficient, and reliable inactivation of pathogens in blood products. The invention contemplates inactivation methods using the new psoralens which do not compromise the function of blood products for transfusion.
Patent AU-640462-B2 (AU)
Title: Heat-shrinkable envelope
IPC: B29C61/06
Filed: 1991-03-07
Granted: 1993-08-26
Abstract: The invention relates to a heat shrinkable covering (1) which comprises at least one shrinkable sheet-like film (4), on which a reinforcing component (6) of reinforcing elements in fibre or filament form is arranged. These reinforcing elements are arranged in irregular configuration, for example in the form of a non-woven, felt or irregular fill. <IMAGE>
Patent AU-735062-B2 (AU)
Title: New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: LAVIELLE GILBERT
IPC: A61P25/00
Filed: 1998-06-24
Granted: 2001-06-28
Abstract: Hexahydro-chromeno-Ä3,4-cÜ-pyrrole derivatives of formula (I), their enantiomers, diastereoisomers and salts are new. m = 0-3; n = 0-3; n+m = 2 or 3; p = 1-6; the junction between rings B and C is trans; X = CN or -CONR4R5; R4, R5 = H, 1-6C alkyl, 3-7C cycloalkyl or optionally substituted aryl; A = sigma bond or -NR-CO-, -CO-NR-, -NR-SO2-, or -SO2-NR-; R = H or 1-6C alkyl; R1, R2 = H or 1-6C alkyl; R3 = H or phenyl, naphthyl or heteroaryl (all optionally substituted by one or more halo, 1-6C alkyl or alkoxy, OH, CN, NH2, NO2, COOH, 1-6C perhaloalkyl, sulphonyl, acylamino, 1-6C alkylsulphonyl, or 1-6C alkyl sulphonylamino), aryl or heteroaryl (both substituted by A'-Cy), 2-indolinon-5-yl, or, when A is a sigma bond, aryloxy or arylthio; A' = sigma bond or 1-6C alkylene or alkenylene, (in which one C atom may be replaced by O or S), -NR-CO-, -CO-NR-, -NR-SO2-, or -SO2-NR-; Cy = aryl or heteroaryl (optionally substituted); provided that when n = 0, then m is other than 2, when n = 1, R1, R2 = H, A = sigma bond and p = 1, then R3 is not phenyl nor pyridyl, when n = 1, R1 & R2 = H, A = sigma bond, R3 is not H, when n = 1, R1 & R2 = H, A = -NH-CO-, then R3 is other than H, phenyl, naphthyl, thienyl, furyl, pyrrolyl, pyridyl, (all optionally substituted by one or more halo, trihalomethyl, alkoxy or OH).
Patent AU-647098-B2 (AU)
Title: Method of grinding the surfaces of cutting blades and grinding wheel therefor
Inventor: PEDERSON HARRY
IPC: B23Q1/48
Filed: 1991-03-11
Granted: 1994-03-17
Abstract: A grinding process and wheel are disclosed wherein any or all surfaces of a cutting blade may be generated in a continuous grinding operation utilizing a single grinding wheel having a simple profile. A grinding wheel having a grinding profile comprising an inner conical surface and an adjacent outer narrow substantially flat surface is provided. The inner conical surface rough grinds to generate a roughed blade surface and the adjacent outer narrow substantially flat surface finish grinds the roughed surface to generate a finished blade surface. Computer numerical control (CNC) is utilized to control the relative movement of the grinding wheel and cutting blade along or about a plurality of axes. Inner and outer arcuate grinding surfaces may also be provided for rough grinding.
Patent AU-638832-B2 (AU)
Title: Precious metal article, method for manufacturing same, moldable mixture for use in manufacture of same and method for producing moldable mixture
IPC: C22C1/04
Filed: 1991-05-15
Granted: 1993-07-08
Abstract: There is disclosed a precious metal article (1) which is formed of a solid-phase sintered product of a precious metal powder. For manufacturing the precious metal article, a moldable mixture which contains a precious metal powder and a binder removable by sintering is shaped into a prescribed molded object, and the molded object is then subjected to sintering. The moldable mixture is produced by preparing a precious metal powder, preparing a jellylike cellulose binder by blending a cellulose with water and leaving for a prescribed period of time, and blending the precious metal powder and the jellylike cellulose binder together. The most preferable moldable mixture contains 50 to 90 % by weight of precious metal powder, 0.8 to 8 % by weight of water-soluble cellulose binder, 0.08 to 3 % by weight of a surface-active agent. 0.1 to 3 % by weight of oil, balance water and unavoidable impurities. The precious metal powder preferably contains gold powder and powder of an alloy containing silver or copper, and the gold powder is obtained by submerged-reduction method. <IMAGE>
Patent AU-647788-B2 (AU)
Title: Therapeutic agent
Inventor: GLASS MITCHELL
IPC: A61K38/00
Filed: 1991-05-20
Granted: 1994-03-31
Abstract: There is provided a novel therapeutic agent for use in the prevention or treatment of adult respiratory distress syndrome and for use in the manufacture of a medicament for the prevention or treatment of adult respiratory distress syndrome, as well as a method of prevention or treatment of adult respiratory distress syndrome with the therapeutic agent and a method of treatment of cystic fibrosis with the therapeutic agent in combination with one or more other agents indicated for the treatment of adult respiratory distress syndrome.
Patent AU-709594-B2 (AU)
Title: Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications
Inventor: SETCHELL KENNETH D R
IPC: A61K31/575
Filed: 1996-11-19
Granted: 1999-09-02
Abstract: One aspect of this invention is directed to a pharmacologically acceptable composition including a sulfate of 3 alpha, 7 beta-dihydroxy-5 beta-cholan-24-oic acid (Ursodeoxycholic acid or "UDCA") and a pharmacologically acceptable carrier. In a preferred composition, the sulfate is UDCA-3-sulfate, UDCA-7-sulfate, UDCA-3,7-disulfate, glyco-UDCA-3-sulfate, glyco-UDCA-7-sulfate, glyco-UDCA-3,7-disulfate, tauro-UDCA-3-sulfate, tauro-UDCA-7-sulfate, tauro-UDCA-3,7-disulfate or a combinations thereof. Another aspect of the invention concerns a method of delivering UDCA to a mammal to inhibit or treat a disorder, which includes administering a sulfate of UDCA to the mammal in an amount sufficient to inhibit or treat the disorder. For example, a UDCA sulfate may be used to advantage in inhibiting or treating an inflammatory condition of the gastrointestinal tract, such as colon cancer, rectum cancer, a neoplasm of the colon, a neoplasm of the rectum, carcinogenesis of the colon, carcinogenesis of the rectum, ulcerative colitis, an adenomatous polyp, familial polyposis and the like. A sulfate of UDCA also may be administered to inhibit or treat an inflammatory disorder of the liver. A UDCA sulfate may be used to improve serum biochemistries of liver disease or liver function, to increase bile flow or to decrease biliary secretion of phospholipid or cholesterol. In yet a further aspect, the invention is directed to a method of maintaining an isolated organ by perfusing the organ with a sulfate of UDCA.
Patent AU-593130-B2 (AU)
Title: Process
Inventor: WALSGROVE TIMOTHY CHARLES
IPC: C07B61/00
Filed: 1987-08-27
Granted: 1990-02-01
Abstract: A process for the preparation of a compound of structure (I) <CHEM> in which, each group R is hydrogen, C1-6alkyl, C3-6allyl, phenylC1-6alkyl or 4-hydroxyphenylC1-6alkyl; R<1>, R<2> and R<3> are hydrogen or C1-6alkyl; R<4> is hydrogen or hydroxy: and n is 1 to 3 or a pharmaceutically acceptable salt thereof, which comprises reduction of a compound of structure (II) <CHEM> in which R, R<2> to R<4> and n are as described above and R<5> is hydrogen or a cation, followed by cyclisation of the intermediate so formed, and, optionally, alkylating to form a compound of structure (I) in which R<1> is C1-6alkyl and, optionally, forming a pharmaceutically acceptable salt thereof, characterised in that the reduction of the compound of structure (II) is carried out by catalytic transfer hydrogenation in water as a solvent.
Patent AU-590450-B2 (AU)
Title: Process for the preparation of dibenzothiepin derivative
Inventor: MASAKI MITSUO
IPC: C07C323/62
Filed: 1987-10-01
Granted: 1989-11-02
Abstract: A novel process for the preparation of 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid which shows high anti-inflammatory and analgetic action is disclosed. The process starts from a propiophenone derivative having the formula (II): <CHEM> wherein R<1> is hydrogen or a lower alkyl group, which is once converted into a haloacetal compound via a haloketone compound, and then converted into the desired dibenzothiepin derivative through a combination of rearrangement, hydrolysis and ring closure in variable sequences.
Patent AU-654135-B2 (AU)
Title: Purification of aqueous liquor
Inventor: PAYNE GEOFFREY LAURENCE
IPC: C02F1/56
Filed: 1991-06-20
Granted: 1994-10-27
Abstract: An aqueous suspension of coagulatable material is coagulated by adding polymeric coagulant to the suspension and then separating the resultant coagulated material from the liquor. The coagulatable material may be present in the aqueous suspension as a suspension of suspended solids or as colloidally dispersed solids. The suspension may be coal tailings or other aqueous (generally mineral) suspension. The polymeric material must be a low molecular weight, highly ionic, polymeric material. It is added to the aqueous suspension while in the form of polymeric particles having a size mainly above 30  mu m and that will dissolve into the suspension and coagulate the coagulatable material. A counterionic, high molecular weight, flocculant is generally added subsequently in order to flocculate the coagulated material.
Patent AU-737456-B2 (AU)
Title: 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
Inventor: LEONARDI AMEDEO
IPC: C07D407/06
Filed: 1998-07-31
Granted: 2001-08-23
Abstract: Disclosed herein are novel compounds and methods for the treatment of disorders of the lower urinary tract. The novel compounds are aniline derivatives substituted at position 2 of the aniline ring. The methods comprise the administration of the novel compounds of the invention, and other compounds that bind to 5HT1A receptors, for treating disorders of the lower urinary tract.
Patent AU-756693-B2 (AU)
Title: Stabilized bioactive preparations and methods of use
Inventor: DELLAMARY LUIS A
IPC: A61K9/22
Filed: 1998-09-29
Granted: 2003-01-23
Abstract: Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a hydrofluoroalkane propellant. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as, by settling or flocculation. In particularly preferred embodiments, the stabilized dispersions may be administered to the lung of a patient using a metered dose inhaler.
Patent DE-1937103-B2 (DE)
Title: Standard lamp foot with dish covering discs - has downward-directed threaded sleeve formed on upper disc to hold stand pipe
IPC: F21V21/06
Filed: 1969-07-22
Abstract: Standard lamp has a standard pipe and a foot, covered with a dish, with internal discs which are held by an incurved dish edge support; a threaded sleeve is formed on one disc for screwing in the pipe. Pref. the other disc is positioned on the downward-directed threaded sleeve formed on the upper disc. A metal disc has a downward-directed edge ensuring floor freedom under the lowermost disc; an insertion bore is in this edge and the edge of the cover disc. The foot has sufficient wt. for stability, with only a low height, and the connection to the pipe is simple.
Patent DE-1951528-B2 (DE)
Title: Conveyor unit for filling and closing machines - using slide adjustable by drive lever on horizontal rods with rollers and swivel lever
IPC: B65B3/02
Filed: 1969-10-13
Abstract: Conveyor is used with filling and closing machines, where the packages are conveyed to individual processing points for filling and closing by elements moving to and fro in a longitudinal direction as well as capable of lifting and lowering. A moulding cell (3) without a base receiving an empty packaging cover (6) is adjustable by a drive lever on a slide (7) carried on two horizontal rods (8) with a pair of rods (9) directed downwards being fitted to the lower side of the slide. The longer of the two rods (9) having a guide shoe (11) at the lower end runs in the end position of the drive lever on to a roller (14) attached with a second roller to a swivel lever (13) with the filling of the packages taking place with the moulding cell raised and the ejection of the filled and closed packages (22) by the succeeding empty packaging cover introduced into the moulding cell.
Patent DE-1951767-B2 (DE)
Title: Adjustable signal generator with high spectral purity - has phase loop and first and second phase loops
IPC: H03L7/187
Filed: 1969-10-14
Abstract: The variable-frequency signal generator has two control loopsto block the phase loop whilst the frequency is being adjusted and to release the phase loop once the frequency approximation is complete. A third control loop comes into operation at the same time as the phase loop and contains a phase detector (8). The phase detector has a centering circuit (11) that constantly maintains the output voltage of the phase loop's phase detector at zero. The advantage of the extra loop lies in its giving the generator high spectral purity and low phase jitter.
Patent DE-2014110-B2 (DE)
Title: Circuit for matching DC coupled logic circuits - has rectifier diode connecting secondary of transformer to inverting transistor
IPC: H03K19/003
Filed: 1970-03-19
Abstract: The circuit matches fail-safe logic circuits of the type described in DS 1933713 to dc coupled logic circuits. DC isolation is achieved with a transformer. The secondary winding of the transformer (1) is connected via a rectifying chide (2) to the base of a transistor (4) acting as an invertor. The transistor has a resistor (3) from base to ground and another (5) from collector to supply. Dynamic signals are then converted into static signals.